Statistics
Publications
11
Citations
1.2K
H-Index
11
Active since
1983
Affiliations
F. L. Meyskens is an author at University of Arizona specializing in medicine, oncology, and pharmacology.
Publications per year
1983–2010
11
11
Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
F. L. Meyskens, Eugene W. Gerner · PubMed · 1999 · 340 citations · Full text
Medicine, Oncology, Pharmacology +14
F. L. Meyskens, Earl A. Surwit, Thomas E. Moon et al. · JNCI Journal of the National Cancer Institute · 1994 · 268 citations · Full text
Medicine, Gynecology, Oncology +17
Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome.
Bernard R. Greenberg, B G M Durie, Tammy Barnett et al. · PubMed · 1985 · 52 citations
Medicine, Hematology, Pharmacology +17
Phase I trial of retinol in cancer patients.
Gary E. Goodman, D S Alberts, D L Earnst et al. · Journal of Clinical Oncology · 1983 · 43 citations
Medicine, Oncology, Pharmacology +15
1–5 of 11